Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Hemorrhage 13Neoplasms 7Leiomyoma 7Breast Neoplasms 6Postoperative Hemorrhage 4Hematologic Neoplasms 4Thrombocytopenia 3Myofibroma 3Meningioma 3Blood Loss, Surgical 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Seroma 2Seizures 2Prostatic Neoplasms 2Postoperative Complications 2Ovarian Neoplasms 2Menorrhagia 2Head and Neck Neoplasms 2Colonic Neoplasms 2Brain Neoplasms 2Bone Neoplasms 2Wrist Fractures 1Urologic Diseases 1Urinary Tract Infections 1Urinary Retention 1Thromboembolism 1Staphylococcal Infections 1Spasm 1Sleep Initiation and Maintenance Disorders 1

Interventions

Fibrin Tissue Adhesive 4Drainage 3Tranexamic Acid 2Surgical Procedures, Operative 2Swimming 1Surveys and Questionnaires 1Sodium Chloride 1Punctures 1Negative-Pressure Wound Therapy 1Methylprednisolone Hemisuccinate 1Congresses as Topic 1Blood Specimen Collection 1Athletic Tape 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Seroma × Tranexamic Acid × Clear all
NCT03738527 2021-02-21

SEROMA

Hamilton Health Sciences Corporation

Phase 4 Unknown
100 enrolled
Breast

Breast Neoplasms, Hematoma, Seroma

NCT02627560 2020-05-12

The Effect of Topical Tranexamic Acid on Bleeding and Seroma Formation in After Undergoing Mastectomy

St. Olavs Hospital

Phase 4 Completed
202 enrolled
Breast

Breast Neoplasms, Postoperative Hemorrhage, Seroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡